RECITALSSecond Loan Modification Agreement • January 13th, 1998 • Endogen Inc • In vitro & in vivo diagnostic substances
ENDOGEN, INC.Endogen Inc • January 13th, 1998 • In vitro & in vivo diagnostic substances
FOR VALUE RECEIVED, the undersigned, ENDOGEN, INC., a Massachusetts corporation (the "Borrower"), promises to pay to the order of Silicon Valley Bank, a California-chartered bank ("Bank"), at such place as the holder hereof may designate, in lawful money of the United States of America, the aggregate unpaid principal amount of all advances ("Advances") made by Bank to Borrower in accordance with the terms of the Loan and Security Agreement between Borrower and Bank dated August 31, 1997, as amended from time to time (the "Loan Agreement"), up to a maximum principal amount of TWO HUNDRED FIFTY THOUSAND AND NO/100THS Dollars ($250,000), until paid in full. Borrower shall also pay interest on the aggregate unpaid principal amount of such Advances at the rates and in accordance with the terms of the Loan Agreement. The entire principal amount and all accrued interest shall be due and payable on MARCH 27, 2001.
